UroGen Pharma is trading 4.34% up now at $43.55, amid supportive broader-market conditions.
- No fresh company-specific announcement was identified for September 16, 2026.
- Latest company coverage centers on its September 15 investor conference presentation.
- The Nasdaq Composite is up 0.67% as investors digest the Federal Reserve’s 25-basis-point rate hike and await further policy guidance.